M42, the global tech-enabled health powerhouse based in Abu Dhabi, will launch the M42 Microbiome Wellness Program, with an aim to revolutionize gut health.
This groundbreaking initiative combines advanced DNA sequencing technology with personalized consultations to set new standards for well-being.
The program is available at Mubadala Health Dubai, emphasizing M42’s commitment to redefining health and wellness globally. It is set to be launched at other M42 assets such as Healthpoint in the future.
Dr. Pranab Gyawali, Consultant Gastroenterologist at Mubadala Health Dubai, said that optimizing the microbiome is a transformative path to overall health. Recent advancements in DNA technology and AI have paved the way for a unique microbiome test using cutting-edge sequencing techniques. This test generates a comprehensive 60-page report, providing valuable insights for personalized recommendations by healthcare professionals.
The exclusive program, featuring the advanced shotgun metagenomic sequencing technology, provides quick turnaround times and is licensed by the Ministry of Health and Prevention. It offers tailored solutions for diverse health goals, from addressing gut issues to enhancing sports performance, weight management and diabetes management.
Describing the microbiome, Dr. Gyawali stated that, “In a nutshell, the microbiome comprises the diverse community of bacteria, viruses and fungi residing within the intestine. These microorganisms, along with the metabolites they produce, play a crucial role in various bodily functions such as immunity, digestion and brain functioning. We now recognize the significance of these products in contributing to and enhancing the overall well-being of the body.”
The program holds potential in sports performance by targeting specific gut bacteria that enhance athletic abilities through lactic acid metabolism and muscle recovery promotion, as per the statement.
